Johnson & Johnson (JNJ) Tops Q2 EPS by 5c; Reaffirms Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $147.91 +1.49%
Revenue Growth %: -13.4%
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -13.4%
Financial Fact:
Selling, marketing and administrative expenses: 4.77B
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.28, $0.05 better than the analyst estimate of $1.23. Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.22 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Johnson & Johnson (JNJ) to Buy, 'Steady outlook, low expectations'
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
